Physician profile
John Mark Shie
NPI 1356328439
$6,906.51
in general payments reported to CMS, 2019-2025
38 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,368 · 2020: $669 · 2021: $1,292 · 2022: $1,945 · 2023: $1,252 · 2024: $269 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,633.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,029.28 | 2019-2023 | Liletta, Orilissa, Lo Loestrin Fe |
| Aspira Women'S Health INC | $519.38 | 2020-2024 | Ova1 |
| Amgen INC. | $519.09 | 2019-2024 | Evenity, Prolia |
| Gynesonics, INC. | $512.72 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $400.67 | 2020-2024 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $340.60 | 2020-2024 | Slynd |
| Sumitomo Pharma America, INC. | $329.18 | 2023-2024 | Myfembree |
| Therapeuticsmd, INC. | $297.68 | 2019-2022 | |
| Hologic Sales and Service, LLC | $240.01 | 2019-2023 | Acessa Provu System, Fluent Fluid Management System |
| Medicem INC. | $223.94 | 2021-2023 | |
| Myovant Sciences INC. | $221.59 | 2021-2022 | |
| Lupin INC. | $196.79 | 2019 | |
| Novo Nordisk INC | $189.79 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $183.23 | 2019-2024 | Gardasil 9, Gardasil |
| Mayne Pharma Commercial LLC | $172.50 | 2022-2023 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $134.49 | 2022 | |
| Avion Pharmaceuticals | $120.75 | 2019-2022 | |
| Agile Therapeutics, INC. | $118.41 | 2021-2024 | Twirla |
| Avanos Medical | $115.56 | 2019 | |
| Coopersurgical, INC. | $113.12 | 2019-2023 | Paragard T 380a |
| Currax Pharmaceuticals LLC | $99.25 | 2019-2023 | Contrave, Nexlizet, Nexletol |
| Biogen, INC. | $97.47 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $96.37 | 2019-2022 | |
| Evofem Biosciences, INC. | $90.12 | 2021-2022 | |
| Optumhealth Care Solutions, LLC | $88.49 | 2023-2025 | Eitan Medical, Vivify Health Care Team Portal 001, Vivify Health Care Team Portal |
| Pfizer INC. | $83.75 | 2019-2024 | |
| Ethicon US, LLC | $63.24 | 2020-2021 | |
| Organon LLC | $55.94 | 2021-2023 | Nexplanon |
| Mylan Pharmaceuticals INC. | $43.35 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $41.49 | 2019 | |
| Dysis Medical, INC. | $34.89 | 2022 | |
| Scynexis, INC. | $31.93 | 2022 | |
| Medtronic Minimed, INC. | $24.25 | 2019 | |
| Convatec INC. | $18.00 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.49 | 2020 | |
| Vertical Pharmaceuticals, LLC | $16.00 | 2019 | |
| Meditrina | $14.25 | 2024 | |
| Urovant Sciences INC | $12.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Shie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.